| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gait | 41 | 2025 | 380 | 8.390 |
Why?
|
| Hip Prosthesis | 34 | 2022 | 442 | 5.530 |
Why?
|
| Knee Joint | 33 | 2025 | 567 | 5.420 |
Why?
|
| Arthroplasty, Replacement, Knee | 23 | 2025 | 557 | 5.280 |
Why?
|
| Knee Prosthesis | 22 | 2020 | 203 | 4.480 |
Why?
|
| Prosthesis Failure | 32 | 2021 | 414 | 4.180 |
Why?
|
| Arthroplasty, Replacement, Hip | 30 | 2021 | 686 | 3.820 |
Why?
|
| Polyethylene | 19 | 2020 | 93 | 3.810 |
Why?
|
| Walking | 15 | 2022 | 237 | 3.730 |
Why?
|
| Models, Biological | 16 | 2018 | 304 | 2.860 |
Why?
|
| Biomechanical Phenomena | 40 | 2022 | 516 | 2.780 |
Why?
|
| Biocompatible Materials | 13 | 2020 | 72 | 2.680 |
Why?
|
| Cartilage, Articular | 16 | 2020 | 265 | 2.640 |
Why?
|
| Materials Testing | 24 | 2021 | 102 | 2.590 |
Why?
|
| Hip Joint | 13 | 2016 | 246 | 2.520 |
Why?
|
| Equipment Failure Analysis | 21 | 2016 | 79 | 2.510 |
Why?
|
| Osteoarthritis, Hip | 12 | 2018 | 81 | 2.480 |
Why?
|
| Polyethylenes | 12 | 2020 | 31 | 2.450 |
Why?
|
| Osteoarthritis, Knee | 13 | 2025 | 293 | 2.250 |
Why?
|
| Titanium | 17 | 2023 | 141 | 2.120 |
Why?
|
| Prosthesis Design | 22 | 2021 | 390 | 2.020 |
Why?
|
| Humans | 117 | 2025 | 23169 | 1.900 |
Why?
|
| Range of Motion, Articular | 17 | 2019 | 563 | 1.880 |
Why?
|
| Alloys | 16 | 2021 | 76 | 1.820 |
Why?
|
| Middle Aged | 52 | 2025 | 8000 | 1.640 |
Why?
|
| Tibia | 10 | 2022 | 192 | 1.640 |
Why?
|
| Male | 60 | 2025 | 12556 | 1.550 |
Why?
|
| Metals | 9 | 2022 | 99 | 1.480 |
Why?
|
| Aged | 45 | 2025 | 7498 | 1.440 |
Why?
|
| Shoes | 5 | 2022 | 30 | 1.430 |
Why?
|
| Female | 58 | 2025 | 13059 | 1.420 |
Why?
|
| Protein Tyrosine Phosphatases | 4 | 2014 | 9 | 1.420 |
Why?
|
| Stress, Mechanical | 22 | 2020 | 124 | 1.360 |
Why?
|
| Surface Properties | 29 | 2021 | 106 | 1.330 |
Why?
|
| Chondrocytes | 9 | 2015 | 97 | 1.320 |
Why?
|
| Knee | 7 | 2017 | 38 | 1.320 |
Why?
|
| Corrosion | 18 | 2022 | 92 | 1.270 |
Why?
|
| Mechanical Phenomena | 7 | 2022 | 20 | 1.180 |
Why?
|
| Europium | 3 | 2020 | 3 | 1.110 |
Why?
|
| Stearates | 3 | 2020 | 3 | 1.110 |
Why?
|
| Prosthesis-Related Infections | 4 | 2023 | 175 | 1.090 |
Why?
|
| Steel | 2 | 2020 | 2 | 1.060 |
Why?
|
| Pressure | 6 | 2020 | 50 | 1.040 |
Why?
|
| Aluminum Oxide | 3 | 2019 | 5 | 1.030 |
Why?
|
| Weight-Bearing | 18 | 2020 | 126 | 0.960 |
Why?
|
| Aged, 80 and over | 24 | 2020 | 3754 | 0.960 |
Why?
|
| Vitallium | 6 | 2013 | 21 | 0.960 |
Why?
|
| Joint Instability | 2 | 2025 | 308 | 0.950 |
Why?
|
| Nickel | 3 | 2021 | 20 | 0.930 |
Why?
|
| Prostheses and Implants | 8 | 2016 | 129 | 0.930 |
Why?
|
| Machine Learning | 1 | 2025 | 59 | 0.880 |
Why?
|
| Postoperative Complications | 5 | 2017 | 824 | 0.860 |
Why?
|
| Anterior Cruciate Ligament | 3 | 2018 | 134 | 0.850 |
Why?
|
| Dental Implants | 3 | 2012 | 9 | 0.840 |
Why?
|
| Chitosan | 1 | 2023 | 7 | 0.810 |
Why?
|
| Nanotubes | 1 | 2023 | 7 | 0.810 |
Why?
|
| Muscle, Skeletal | 11 | 2018 | 323 | 0.790 |
Why?
|
| Adult | 27 | 2019 | 7031 | 0.780 |
Why?
|
| Electromyography | 7 | 2018 | 68 | 0.750 |
Why?
|
| Movement | 8 | 2016 | 103 | 0.740 |
Why?
|
| Cobalt | 8 | 2016 | 76 | 0.730 |
Why?
|
| Arthroplasty, Replacement | 3 | 2020 | 123 | 0.720 |
Why?
|
| Bioreactors | 4 | 2014 | 6 | 0.720 |
Why?
|
| Metal-on-Metal Joint Prostheses | 5 | 2014 | 33 | 0.720 |
Why?
|
| Chromium | 7 | 2016 | 62 | 0.710 |
Why?
|
| Cell Culture Techniques | 4 | 2014 | 30 | 0.710 |
Why?
|
| Proteoglycans | 5 | 2017 | 119 | 0.690 |
Why?
|
| Femur | 6 | 2019 | 296 | 0.680 |
Why?
|
| Animals | 27 | 2021 | 3272 | 0.670 |
Why?
|
| Mitochondrial Proteins | 2 | 2011 | 38 | 0.660 |
Why?
|
| Ankle Injuries | 3 | 2016 | 8 | 0.610 |
Why?
|
| Feedback, Sensory | 1 | 2019 | 9 | 0.610 |
Why?
|
| Smartphone | 1 | 2019 | 15 | 0.610 |
Why?
|
| Joint Prosthesis | 2 | 2018 | 68 | 0.600 |
Why?
|
| Foot | 2 | 2016 | 40 | 0.600 |
Why?
|
| Arthroplasty, Replacement, Ankle | 1 | 2018 | 2 | 0.580 |
Why?
|
| Friction | 10 | 2020 | 16 | 0.570 |
Why?
|
| Feedback | 2 | 2016 | 33 | 0.560 |
Why?
|
| Cattle | 13 | 2020 | 112 | 0.550 |
Why?
|
| Lipopolysaccharides | 3 | 2013 | 87 | 0.550 |
Why?
|
| Device Removal | 6 | 2020 | 68 | 0.540 |
Why?
|
| Electrochemistry | 9 | 2017 | 39 | 0.520 |
Why?
|
| Cicatrix | 1 | 2016 | 8 | 0.510 |
Why?
|
| Synovial Fluid | 5 | 2021 | 82 | 0.500 |
Why?
|
| Severity of Illness Index | 4 | 2013 | 811 | 0.500 |
Why?
|
| Recovery of Function | 4 | 2014 | 242 | 0.490 |
Why?
|
| Stainless Steel | 4 | 2021 | 14 | 0.490 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 2 | 2014 | 2 | 0.480 |
Why?
|
| 14-3-3 Proteins | 2 | 2014 | 3 | 0.480 |
Why?
|
| Joints | 2 | 2016 | 67 | 0.480 |
Why?
|
| Walking Speed | 1 | 2016 | 34 | 0.480 |
Why?
|
| Auditory Perception | 1 | 2016 | 31 | 0.480 |
Why?
|
| Cartilage | 2 | 2019 | 70 | 0.470 |
Why?
|
| Purkinje Cells | 1 | 2014 | 2 | 0.450 |
Why?
|
| Algorithms | 2 | 2014 | 310 | 0.440 |
Why?
|
| Radiography | 8 | 2018 | 528 | 0.430 |
Why?
|
| RNA, Messenger | 7 | 2014 | 281 | 0.420 |
Why?
|
| Acetabulum | 5 | 2012 | 165 | 0.420 |
Why?
|
| Hyperkinesis | 1 | 2013 | 8 | 0.420 |
Why?
|
| Metals, Heavy | 1 | 2013 | 4 | 0.420 |
Why?
|
| Memory | 1 | 2014 | 211 | 0.410 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2013 | 17 | 0.410 |
Why?
|
| Motion | 3 | 2011 | 20 | 0.410 |
Why?
|
| Rotation | 6 | 2019 | 109 | 0.410 |
Why?
|
| Activities of Daily Living | 1 | 2015 | 355 | 0.400 |
Why?
|
| Beryllium | 1 | 2013 | 1 | 0.400 |
Why?
|
| Microscopy, Electron, Scanning | 11 | 2013 | 65 | 0.400 |
Why?
|
| Hippocampus | 1 | 2014 | 200 | 0.400 |
Why?
|
| Computer Simulation | 6 | 2020 | 174 | 0.390 |
Why?
|
| Blood Proteins | 1 | 2012 | 17 | 0.390 |
Why?
|
| Baseball | 4 | 2017 | 91 | 0.390 |
Why?
|
| Mouth | 1 | 2012 | 12 | 0.380 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 26 | 0.360 |
Why?
|
| Glioblastoma | 1 | 2011 | 12 | 0.360 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 35 | 0.360 |
Why?
|
| Gene Expression | 2 | 2015 | 176 | 0.360 |
Why?
|
| Particle Size | 7 | 2013 | 38 | 0.350 |
Why?
|
| Microcirculation | 5 | 2007 | 25 | 0.350 |
Why?
|
| Glycoproteins | 3 | 2007 | 41 | 0.350 |
Why?
|
| Fragile X Syndrome | 1 | 2013 | 186 | 0.350 |
Why?
|
| Risk Factors | 8 | 2017 | 1988 | 0.340 |
Why?
|
| Brain Neoplasms | 1 | 2011 | 90 | 0.340 |
Why?
|
| Practice Guidelines as Topic | 1 | 2012 | 243 | 0.330 |
Why?
|
| Time Factors | 12 | 2016 | 1275 | 0.330 |
Why?
|
| Zirconium | 2 | 2019 | 4 | 0.320 |
Why?
|
| Transplants | 1 | 2009 | 9 | 0.320 |
Why?
|
| Reoperation | 7 | 2014 | 743 | 0.310 |
Why?
|
| Graft Survival | 1 | 2009 | 84 | 0.310 |
Why?
|
| Muscle Strength | 5 | 2019 | 99 | 0.310 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2006 | 49 | 0.300 |
Why?
|
| Equipment Design | 5 | 2019 | 122 | 0.300 |
Why?
|
| Hyaluronic Acid | 3 | 2021 | 33 | 0.300 |
Why?
|
| Keratinocytes | 1 | 2008 | 5 | 0.300 |
Why?
|
| Osteolysis | 3 | 2016 | 112 | 0.290 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2008 | 6 | 0.290 |
Why?
|
| Models, Theoretical | 2 | 2020 | 77 | 0.290 |
Why?
|
| Hydrogen-Ion Concentration | 8 | 2021 | 126 | 0.290 |
Why?
|
| Ankle Joint | 4 | 2016 | 38 | 0.290 |
Why?
|
| Stromal Cells | 1 | 2008 | 33 | 0.290 |
Why?
|
| Dental Alloys | 3 | 2013 | 4 | 0.290 |
Why?
|
| Anterior Cruciate Ligament Injuries | 2 | 2022 | 142 | 0.280 |
Why?
|
| Skin Neoplasms | 1 | 2008 | 68 | 0.280 |
Why?
|
| Nitrogen | 2 | 2021 | 4 | 0.270 |
Why?
|
| Polyurethanes | 2 | 2006 | 5 | 0.270 |
Why?
|
| Adaptation, Biological | 1 | 2007 | 2 | 0.270 |
Why?
|
| Synovial Membrane | 1 | 2007 | 45 | 0.270 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2008 | 164 | 0.260 |
Why?
|
| Joint Diseases | 1 | 2007 | 87 | 0.260 |
Why?
|
| Case-Control Studies | 5 | 2016 | 481 | 0.250 |
Why?
|
| Elbow Joint | 3 | 2015 | 113 | 0.250 |
Why?
|
| In Vitro Techniques | 3 | 2016 | 152 | 0.250 |
Why?
|
| Femur Head | 1 | 2006 | 43 | 0.250 |
Why?
|
| Treatment Outcome | 10 | 2016 | 2971 | 0.250 |
Why?
|
| Molybdenum | 4 | 2016 | 15 | 0.250 |
Why?
|
| Exercise Test | 1 | 2006 | 112 | 0.240 |
Why?
|
| Microscopy, Electron, Transmission | 5 | 2013 | 21 | 0.240 |
Why?
|
| Implants, Experimental | 2 | 2021 | 32 | 0.240 |
Why?
|
| Osteoarthritis | 2 | 2022 | 277 | 0.240 |
Why?
|
| Tissue Engineering | 2 | 2006 | 24 | 0.230 |
Why?
|
| Foreign Bodies | 2 | 2003 | 21 | 0.230 |
Why?
|
| Young Adult | 7 | 2016 | 1671 | 0.230 |
Why?
|
| Saliva, Artificial | 4 | 2013 | 4 | 0.230 |
Why?
|
| Intervertebral Disc | 1 | 2006 | 114 | 0.230 |
Why?
|
| Foreign-Body Reaction | 3 | 2014 | 16 | 0.230 |
Why?
|
| Immunohistochemistry | 3 | 2011 | 338 | 0.230 |
Why?
|
| Cluster Analysis | 1 | 2025 | 41 | 0.230 |
Why?
|
| Cell Survival | 3 | 2017 | 98 | 0.220 |
Why?
|
| Reproducibility of Results | 5 | 2022 | 592 | 0.220 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2004 | 3 | 0.220 |
Why?
|
| Spinal Diseases | 1 | 2006 | 107 | 0.220 |
Why?
|
| Finite Element Analysis | 3 | 2020 | 23 | 0.220 |
Why?
|
| Reference Values | 3 | 2017 | 167 | 0.220 |
Why?
|
| Cells, Cultured | 4 | 2014 | 472 | 0.220 |
Why?
|
| Physical Examination | 2 | 2015 | 87 | 0.220 |
Why?
|
| Microspheres | 1 | 2004 | 24 | 0.220 |
Why?
|
| Up-Regulation | 4 | 2011 | 144 | 0.210 |
Why?
|
| Metal Nanoparticles | 3 | 2013 | 7 | 0.210 |
Why?
|
| Shoulder Joint | 3 | 2015 | 504 | 0.210 |
Why?
|
| Sensitivity and Specificity | 4 | 2012 | 449 | 0.200 |
Why?
|
| Gentamicins | 1 | 2023 | 16 | 0.200 |
Why?
|
| Transplantation, Homologous | 2 | 2017 | 193 | 0.200 |
Why?
|
| Bone Cements | 3 | 2012 | 79 | 0.190 |
Why?
|
| Analysis of Variance | 3 | 2012 | 234 | 0.190 |
Why?
|
| Brain | 1 | 2009 | 1200 | 0.190 |
Why?
|
| Ceramics | 2 | 2019 | 13 | 0.190 |
Why?
|
| Internationality | 3 | 2012 | 18 | 0.190 |
Why?
|
| Inflammation | 3 | 2020 | 229 | 0.180 |
Why?
|
| Healthy Volunteers | 2 | 2019 | 29 | 0.180 |
Why?
|
| Mice | 3 | 2021 | 1232 | 0.180 |
Why?
|
| Pain | 4 | 2013 | 326 | 0.180 |
Why?
|
| Lubrication | 3 | 2020 | 5 | 0.170 |
Why?
|
| Osseointegration | 1 | 2021 | 64 | 0.170 |
Why?
|
| In Situ Hybridization | 2 | 2011 | 47 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 131 | 0.170 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 1427 | 0.170 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 363 | 0.160 |
Why?
|
| Mass Spectrometry | 1 | 2000 | 26 | 0.160 |
Why?
|
| Cross-Linking Reagents | 2 | 2011 | 10 | 0.160 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2000 | 21 | 0.160 |
Why?
|
| Staphylococcal Infections | 1 | 2021 | 155 | 0.160 |
Why?
|
| Risk Assessment | 2 | 2012 | 552 | 0.150 |
Why?
|
| Muscle Contraction | 2 | 2015 | 67 | 0.150 |
Why?
|
| Carbon | 3 | 2013 | 7 | 0.150 |
Why?
|
| Feasibility Studies | 2 | 2016 | 210 | 0.150 |
Why?
|
| Bone Density | 2 | 2011 | 136 | 0.140 |
Why?
|
| Shoulder | 2 | 2017 | 140 | 0.140 |
Why?
|
| Body Mass Index | 2 | 2018 | 382 | 0.140 |
Why?
|
| Proprioception | 2 | 2014 | 18 | 0.140 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2014 | 35 | 0.130 |
Why?
|
| Stair Climbing | 1 | 2017 | 5 | 0.130 |
Why?
|
| Age Factors | 2 | 2016 | 639 | 0.130 |
Why?
|
| Gene Expression Regulation | 3 | 2009 | 230 | 0.130 |
Why?
|
| Lower Extremity | 1 | 2017 | 33 | 0.130 |
Why?
|
| Reference Standards | 3 | 2018 | 22 | 0.130 |
Why?
|
| Extremities | 1 | 2016 | 24 | 0.130 |
Why?
|
| Upper Extremity | 1 | 2017 | 51 | 0.130 |
Why?
|
| Principal Component Analysis | 1 | 2016 | 18 | 0.130 |
Why?
|
| Mesocricetus | 6 | 2007 | 7 | 0.120 |
Why?
|
| Escherichia coli | 2 | 2013 | 46 | 0.120 |
Why?
|
| Cricetinae | 6 | 2007 | 34 | 0.120 |
Why?
|
| Spectrum Analysis | 3 | 2011 | 7 | 0.120 |
Why?
|
| Cadaver | 3 | 2022 | 275 | 0.120 |
Why?
|
| Pilot Projects | 3 | 2013 | 378 | 0.120 |
Why?
|
| Allografts | 1 | 2017 | 144 | 0.120 |
Why?
|
| Hamstring Muscles | 1 | 2016 | 13 | 0.120 |
Why?
|
| Thigh | 1 | 2015 | 26 | 0.120 |
Why?
|
| Rheology | 2 | 2006 | 2 | 0.120 |
Why?
|
| Deltoid Muscle | 1 | 2015 | 5 | 0.120 |
Why?
|
| Cytokines | 1 | 2017 | 206 | 0.120 |
Why?
|
| Genome, Human | 1 | 2015 | 34 | 0.120 |
Why?
|
| Patient Positioning | 1 | 2015 | 34 | 0.120 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 60 | 0.120 |
Why?
|
| Autopsy | 1 | 2016 | 257 | 0.120 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2014 | 2 | 0.110 |
Why?
|
| Diacylglycerol Kinase | 1 | 2014 | 4 | 0.110 |
Why?
|
| Vesicular Transport Proteins | 1 | 2014 | 8 | 0.110 |
Why?
|
| Protein Transport | 1 | 2014 | 29 | 0.110 |
Why?
|
| Quadriceps Muscle | 2 | 2016 | 25 | 0.110 |
Why?
|
| Endoplasmic Reticulum | 1 | 2014 | 25 | 0.110 |
Why?
|
| Child | 3 | 2015 | 1171 | 0.110 |
Why?
|
| Mitochondria | 1 | 2014 | 54 | 0.110 |
Why?
|
| Pyramidal Cells | 1 | 2014 | 35 | 0.110 |
Why?
|
| Chi-Square Distribution | 2 | 2012 | 125 | 0.110 |
Why?
|
| Oxidation-Reduction | 2 | 2011 | 62 | 0.110 |
Why?
|
| NF-kappa B | 1 | 2014 | 104 | 0.110 |
Why?
|
| Cell Line | 1 | 2014 | 250 | 0.110 |
Why?
|
| Anterior Cruciate Ligament Reconstruction | 1 | 2016 | 137 | 0.110 |
Why?
|
| Gamma Rays | 2 | 2011 | 11 | 0.110 |
Why?
|
| Sleep | 1 | 2016 | 268 | 0.110 |
Why?
|
| Dental Materials | 1 | 2013 | 3 | 0.110 |
Why?
|
| Membrane Proteins | 1 | 2014 | 151 | 0.100 |
Why?
|
| Interferometry | 2 | 2013 | 6 | 0.100 |
Why?
|
| Microscopy, Electrochemical, Scanning | 1 | 2013 | 1 | 0.100 |
Why?
|
| Task Performance and Analysis | 1 | 2013 | 43 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 357 | 0.100 |
Why?
|
| Rotator Cuff | 1 | 2015 | 208 | 0.100 |
Why?
|
| Adolescent | 3 | 2015 | 1916 | 0.100 |
Why?
|
| Foot Orthoses | 1 | 2013 | 11 | 0.100 |
Why?
|
| Molecular Weight | 3 | 2010 | 22 | 0.100 |
Why?
|
| Macrophages | 1 | 2014 | 91 | 0.100 |
Why?
|
| Bone Malalignment | 1 | 2013 | 15 | 0.100 |
Why?
|
| Orthopedics | 2 | 2012 | 77 | 0.100 |
Why?
|
| Tenodesis | 1 | 2014 | 137 | 0.090 |
Why?
|
| Shear Strength | 1 | 2012 | 7 | 0.090 |
Why?
|
| Graphite | 1 | 2011 | 2 | 0.090 |
Why?
|
| src-Family Kinases | 1 | 2011 | 6 | 0.090 |
Why?
|
| Germany | 1 | 2011 | 6 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2011 | 6 | 0.090 |
Why?
|
| Somatosensory Disorders | 1 | 2012 | 10 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 37 | 0.090 |
Why?
|
| Vibration | 1 | 2012 | 24 | 0.090 |
Why?
|
| Apoptosis | 2 | 2010 | 196 | 0.090 |
Why?
|
| Aluminum | 1 | 2011 | 9 | 0.090 |
Why?
|
| Neoplasm Grading | 1 | 2011 | 53 | 0.090 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2011 | 8 | 0.090 |
Why?
|
| Logistic Models | 1 | 2012 | 357 | 0.090 |
Why?
|
| Microscopy, Electron | 1 | 2011 | 61 | 0.090 |
Why?
|
| Prosthesis Fitting | 1 | 2011 | 17 | 0.090 |
Why?
|
| Athletic Performance | 1 | 2011 | 15 | 0.090 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2011 | 37 | 0.090 |
Why?
|
| Fractures, Cartilage | 1 | 2010 | 2 | 0.080 |
Why?
|
| Poloxamer | 1 | 2010 | 3 | 0.080 |
Why?
|
| Surface-Active Agents | 1 | 2010 | 5 | 0.080 |
Why?
|
| Suture Anchors | 1 | 2011 | 56 | 0.080 |
Why?
|
| Prosthesis Implantation | 1 | 2010 | 26 | 0.080 |
Why?
|
| Musculoskeletal System | 1 | 2010 | 5 | 0.080 |
Why?
|
| Zygapophyseal Joint | 1 | 2010 | 27 | 0.080 |
Why?
|
| Anisotropy | 1 | 2010 | 35 | 0.080 |
Why?
|
| Neurophysins | 1 | 2009 | 1 | 0.080 |
Why?
|
| Dermoscopy | 1 | 2009 | 1 | 0.080 |
Why?
|
| Vasopressins | 1 | 2009 | 8 | 0.080 |
Why?
|
| Elasticity | 2 | 2004 | 25 | 0.080 |
Why?
|
| Immunoblotting | 1 | 2009 | 54 | 0.080 |
Why?
|
| Glycosaminoglycans | 1 | 2009 | 18 | 0.080 |
Why?
|
| Athletic Injuries | 1 | 2011 | 126 | 0.080 |
Why?
|
| Confidence Intervals | 1 | 2009 | 75 | 0.080 |
Why?
|
| Culture Media, Conditioned | 2 | 2006 | 18 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2006 | 78 | 0.080 |
Why?
|
| Transplantation, Autologous | 1 | 2009 | 98 | 0.080 |
Why?
|
| Collagen | 1 | 2009 | 79 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 2 | 2006 | 115 | 0.080 |
Why?
|
| Chicago | 1 | 2012 | 816 | 0.080 |
Why?
|
| Exercise Therapy | 1 | 2010 | 82 | 0.080 |
Why?
|
| Nitric Oxide | 1 | 2009 | 73 | 0.080 |
Why?
|
| Retrospective Studies | 2 | 2020 | 3026 | 0.080 |
Why?
|
| Tendon Injuries | 1 | 2011 | 151 | 0.080 |
Why?
|
| Capillaries | 3 | 2005 | 10 | 0.080 |
Why?
|
| Chromium Compounds | 1 | 2009 | 3 | 0.080 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2009 | 7 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2009 | 84 | 0.080 |
Why?
|
| Phosphates | 1 | 2009 | 16 | 0.080 |
Why?
|
| Orthopedic Procedures | 1 | 2011 | 222 | 0.070 |
Why?
|
| Tissue Scaffolds | 1 | 2009 | 21 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 1037 | 0.070 |
Why?
|
| Light | 1 | 2009 | 55 | 0.070 |
Why?
|
| Disease Progression | 3 | 2018 | 523 | 0.070 |
Why?
|
| Diskectomy | 1 | 2010 | 167 | 0.070 |
Why?
|
| Bone Transplantation | 1 | 2009 | 153 | 0.070 |
Why?
|
| Adaptation, Physiological | 1 | 2008 | 42 | 0.070 |
Why?
|
| Chromium Alloys | 2 | 2017 | 30 | 0.070 |
Why?
|
| Pain Measurement | 3 | 2018 | 414 | 0.070 |
Why?
|
| Cyanates | 1 | 2006 | 1 | 0.060 |
Why?
|
| Isosorbide | 1 | 2006 | 1 | 0.060 |
Why?
|
| Isocyanates | 1 | 2006 | 1 | 0.060 |
Why?
|
| Matrilin Proteins | 1 | 2006 | 3 | 0.060 |
Why?
|
| Polyesters | 1 | 2006 | 2 | 0.060 |
Why?
|
| Organ Culture Techniques | 1 | 2006 | 12 | 0.060 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 2006 | 4 | 0.060 |
Why?
|
| Arthrography | 1 | 2006 | 23 | 0.060 |
Why?
|
| Biophysical Phenomena | 1 | 2006 | 27 | 0.060 |
Why?
|
| Collagen Type II | 1 | 2006 | 19 | 0.060 |
Why?
|
| Orientation | 1 | 2006 | 5 | 0.060 |
Why?
|
| Biophysics | 1 | 2006 | 33 | 0.060 |
Why?
|
| Porosity | 1 | 2006 | 55 | 0.060 |
Why?
|
| Single-Blind Method | 1 | 2006 | 88 | 0.060 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2006 | 37 | 0.060 |
Why?
|
| Polymers | 1 | 2006 | 36 | 0.060 |
Why?
|
| Aggrecans | 1 | 2006 | 48 | 0.060 |
Why?
|
| Permeability | 2 | 2005 | 94 | 0.060 |
Why?
|
| Debridement | 1 | 2006 | 66 | 0.060 |
Why?
|
| Lumbar Vertebrae | 1 | 2010 | 357 | 0.060 |
Why?
|
| Treatment Failure | 1 | 2006 | 127 | 0.060 |
Why?
|
| Robotics | 1 | 2005 | 20 | 0.060 |
Why?
|
| Guidelines as Topic | 1 | 2005 | 55 | 0.060 |
Why?
|
| Leukocytes | 4 | 2007 | 31 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2009 | 1512 | 0.060 |
Why?
|
| Posture | 3 | 2015 | 56 | 0.060 |
Why?
|
| Physical Stimulation | 1 | 2004 | 9 | 0.060 |
Why?
|
| Disability Evaluation | 2 | 2019 | 218 | 0.060 |
Why?
|
| Arthroplasty | 1 | 2005 | 104 | 0.060 |
Why?
|
| Proteins | 1 | 2005 | 53 | 0.060 |
Why?
|
| Extracellular Matrix | 1 | 2004 | 48 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2004 | 125 | 0.050 |
Why?
|
| Electrochemical Techniques | 2 | 2013 | 7 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2004 | 165 | 0.050 |
Why?
|
| Rest | 1 | 2003 | 28 | 0.050 |
Why?
|
| Calibration | 2 | 2000 | 16 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2019 | 1425 | 0.050 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2021 | 12 | 0.050 |
Why?
|
| Dielectric Spectroscopy | 2 | 2011 | 4 | 0.040 |
Why?
|
| Rats, Zucker | 1 | 2021 | 7 | 0.040 |
Why?
|
| Ovariectomy | 1 | 2021 | 26 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2021 | 68 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2021 | 73 | 0.040 |
Why?
|
| Blood | 1 | 2001 | 17 | 0.040 |
Why?
|
| Neutrophils | 1 | 2021 | 93 | 0.040 |
Why?
|
| Shoulder Injuries | 2 | 2014 | 112 | 0.040 |
Why?
|
| gamma-Globulins | 1 | 2020 | 1 | 0.040 |
Why?
|
| Temperature | 2 | 2012 | 58 | 0.040 |
Why?
|
| Albumins | 1 | 2020 | 18 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2021 | 312 | 0.040 |
Why?
|
| Microscopy, Atomic Force | 1 | 2020 | 4 | 0.040 |
Why?
|
| Spectrophotometry, Atomic | 1 | 2000 | 4 | 0.040 |
Why?
|
| Forecasting | 1 | 2020 | 81 | 0.040 |
Why?
|
| Ultrasonics | 1 | 2000 | 10 | 0.040 |
Why?
|
| Rats | 1 | 2021 | 625 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2021 | 538 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2015 | 774 | 0.040 |
Why?
|
| Absorptiometry, Photon | 2 | 2011 | 79 | 0.040 |
Why?
|
| Cell Death | 2 | 2009 | 34 | 0.040 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 1998 | 28 | 0.030 |
Why?
|
| Software | 1 | 1998 | 49 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1998 | 138 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1048 | 0.030 |
Why?
|
| Interleukins | 1 | 2017 | 21 | 0.030 |
Why?
|
| Muscle Fatigue | 1 | 2017 | 8 | 0.030 |
Why?
|
| Torso | 1 | 2017 | 6 | 0.030 |
Why?
|
| Independent Living | 1 | 2019 | 225 | 0.030 |
Why?
|
| Hardness | 2 | 2012 | 4 | 0.030 |
Why?
|
| Patellar Ligament | 1 | 1997 | 33 | 0.030 |
Why?
|
| Elbow | 1 | 2017 | 40 | 0.030 |
Why?
|
| Patella | 1 | 1997 | 54 | 0.030 |
Why?
|
| Electrodes | 1 | 2016 | 14 | 0.030 |
Why?
|
| Biosensing Techniques | 1 | 2016 | 11 | 0.030 |
Why?
|
| Endothelial Cells | 2 | 2007 | 59 | 0.030 |
Why?
|
| Medical Illustration | 1 | 2015 | 11 | 0.030 |
Why?
|
| Photography | 1 | 2015 | 11 | 0.030 |
Why?
|
| DNA | 1 | 2015 | 95 | 0.030 |
Why?
|
| Exercise | 1 | 2019 | 397 | 0.030 |
Why?
|
| Body Height | 1 | 2015 | 31 | 0.030 |
Why?
|
| Video Recording | 1 | 2015 | 29 | 0.030 |
Why?
|
| Capillary Permeability | 2 | 2007 | 29 | 0.030 |
Why?
|
| Thorax | 1 | 2014 | 10 | 0.030 |
Why?
|
| Knee Injuries | 1 | 2016 | 125 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2013 | 17 | 0.030 |
Why?
|
| Endothelium, Vascular | 2 | 2006 | 46 | 0.030 |
Why?
|
| Adhesiveness | 1 | 2013 | 1 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 2 | 2005 | 69 | 0.030 |
Why?
|
| Diffusion | 1 | 2013 | 24 | 0.030 |
Why?
|
| Water | 1 | 2013 | 29 | 0.030 |
Why?
|
| Europe | 1 | 2013 | 53 | 0.020 |
Why?
|
| Hip Injuries | 1 | 2013 | 7 | 0.020 |
Why?
|
| Asymptomatic Diseases | 1 | 2013 | 10 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2013 | 10 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2013 | 107 | 0.020 |
Why?
|
| Electrons | 1 | 2012 | 16 | 0.020 |
Why?
|
| Microscopy | 1 | 2012 | 10 | 0.020 |
Why?
|
| Spectroscopy, Electron Energy-Loss | 1 | 2011 | 2 | 0.020 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2011 | 4 | 0.020 |
Why?
|
| Serum | 1 | 2011 | 7 | 0.020 |
Why?
|
| Dental Polishing | 1 | 2011 | 1 | 0.020 |
Why?
|
| Sodium Hydroxide | 1 | 2011 | 1 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2011 | 5 | 0.020 |
Why?
|
| Sensory Thresholds | 1 | 2012 | 22 | 0.020 |
Why?
|
| Electric Capacitance | 1 | 2011 | 6 | 0.020 |
Why?
|
| Rupture | 1 | 2011 | 78 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2011 | 24 | 0.020 |
Why?
|
| Reducing Agents | 1 | 2010 | 2 | 0.020 |
Why?
|
| Free Radicals | 1 | 2010 | 7 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 105 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 100 | 0.020 |
Why?
|
| Suture Techniques | 1 | 2011 | 105 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2010 | 8 | 0.020 |
Why?
|
| Talus | 1 | 2010 | 12 | 0.020 |
Why?
|
| Pyridines | 1 | 2010 | 27 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 154 | 0.020 |
Why?
|
| Linear Models | 1 | 2011 | 192 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2011 | 219 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2010 | 70 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 115 | 0.020 |
Why?
|
| Imidazoles | 1 | 2010 | 62 | 0.020 |
Why?
|
| Wound Healing | 1 | 2010 | 113 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2010 | 242 | 0.020 |
Why?
|
| Torque | 1 | 2009 | 18 | 0.020 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2009 | 14 | 0.020 |
Why?
|
| Pain Management | 1 | 2010 | 125 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2010 | 399 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2007 | 31 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2007 | 80 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2006 | 33 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2006 | 11 | 0.020 |
Why?
|
| Body Weight | 1 | 2006 | 129 | 0.020 |
Why?
|
| Body Fluids | 1 | 2005 | 11 | 0.020 |
Why?
|
| Microscopy, Video | 1 | 2005 | 2 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2006 | 51 | 0.020 |
Why?
|
| Microfluidics | 1 | 2005 | 7 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2005 | 62 | 0.010 |
Why?
|
| Mechanics | 1 | 2005 | 3 | 0.010 |
Why?
|
| Nanostructures | 1 | 2005 | 9 | 0.010 |
Why?
|
| Oxygen | 1 | 2005 | 58 | 0.010 |
Why?
|
| Infant | 1 | 2005 | 486 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2005 | 578 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2003 | 68 | 0.010 |
Why?
|